The high-incidence period of Mycoplasma pneumoniae infections 2023/2024 in southeast Germany was associated with a low level of macrolide resistance
Author:
Open Access
- 1 July 2024
- journal article
- letter
- Published by Springer Nature in Infection
- Vol. 52 (6) , 2525-2527
Abstract
No abstract availableKeywords
Funding Information
- Technische Universität Dresden
This publication has 7 references indexed in Scilit:
- Disease burden and macrolide resistance of Mycoplasma pneumoniae infection in adults in the Asia-Pacific regionInternational Journal of Antimicrobial Agents, 2024
- Novel Variant and Known Mutation in 23S rRNA Gene of Mycoplasma pneumoniae , Northern Vietnam, 2023Emerging Infectious Diseases, 2024
- Pneumonia outbreaks due to re-emergence of Mycoplasma pneumoniaeThe Lancet Microbe, 2024
- Mycoplasma pneumoniae epidemic in Denmark, October to December, 2023Eurosurveillance, 2024
- Mycoplasma pneumoniae: gone forever?The Lancet Microbe, 2023
- Update on the Epidemiology of Macrolide-Resistant Mycoplasma pneumoniae in Europe: A Systematic ReviewInfectious Disease Reports, 2021
- Mycoplasma pneumoniae from the Respiratory Tract and BeyondClinical Microbiology Reviews, 2017